These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 33121039)

  • 1. Artesunate Inhibits Growth of Sunitinib-Resistant Renal Cell Carcinoma Cells through Cell Cycle Arrest and Induction of Ferroptosis.
    Markowitsch SD; Schupp P; Lauckner J; Vakhrusheva O; Slade KS; Mager R; Efferth T; Haferkamp A; Juengel E
    Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33121039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells.
    Vakhrusheva O; Erb HHH; Bräunig V; Markowitsch SD; Schupp P; Baer PC; Slade KS; Thomas A; Tsaur I; Puhr M; Culig Z; Cinatl J; Michaelis M; Efferth T; Haferkamp A; Juengel E
    Front Oncol; 2022; 12():789284. PubMed ID: 35198441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artesunate Impairs Growth in Cisplatin-Resistant Bladder Cancer Cells by Cell Cycle Arrest, Apoptosis and Autophagy Induction.
    Zhao F; Vakhrusheva O; Markowitsch SD; Slade KS; Tsaur I; Cinatl J; Michaelis M; Efferth T; Haferkamp A; Juengel E
    Cells; 2020 Dec; 9(12):. PubMed ID: 33316936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shikonin Inhibits Cell Growth of Sunitinib-Resistant Renal Cell Carcinoma by Activating the Necrosome Complex and Inhibiting the AKT/mTOR Signaling Pathway.
    Markowitsch SD; Vakhrusheva O; Schupp P; Akele Y; Kitanovic J; Slade KS; Efferth T; Thomas A; Tsaur I; Mager R; Haferkamp A; Juengel E
    Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis.
    Jeong DE; Song HJ; Lim S; Lee SJ; Lim JE; Nam DH; Joo KM; Jeong BC; Jeon SS; Choi HY; Lee HW
    Oncotarget; 2015 Oct; 6(32):33046-64. PubMed ID: 26426994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of reactive oxygen species to ovarian cancer cell growth arrest and killing by the anti-malarial drug artesunate.
    Greenshields AL; Shepherd TG; Hoskin DW
    Mol Carcinog; 2017 Jan; 56(1):75-93. PubMed ID: 26878598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Relationship between Ferroptosis and Tumors: A Novel Landscape for Therapeutic Approach.
    Xia X; Fan X; Zhao M; Zhu P
    Curr Gene Ther; 2019; 19(2):117-124. PubMed ID: 31264548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artesunate induces apoptosis, autophagy and ferroptosis in diffuse large B cell lymphoma cells by impairing STAT3 signaling.
    Chen Y; Wang F; Wu P; Gong S; Gao J; Tao H; Shen Q; Wang S; Zhou Z; Jia Y
    Cell Signal; 2021 Dec; 88():110167. PubMed ID: 34628002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of the Morphological, Functional and Molecular Changes in Sunitinib-Resistant Renal Cell Carcinoma Cells.
    Kamli H; Glenda GC; Li L; Vesey DA; Morais C
    J Kidney Cancer VHL; 2018; 5(3):1-9. PubMed ID: 30109169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells.
    Eling N; Reuter L; Hazin J; Hamacher-Brady A; Brady NR
    Oncoscience; 2015; 2(5):517-32. PubMed ID: 26097885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amygdalin inhibits the growth of renal cell carcinoma cells in vitro.
    Juengel E; Thomas A; Rutz J; Makarevic J; Tsaur I; Nelson K; Haferkamp A; Blaheta RA
    Int J Mol Med; 2016 Feb; 37(2):526-32. PubMed ID: 26709398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-malarial drug artesunate causes cell cycle arrest and apoptosis of triple-negative MDA-MB-468 and HER2-enriched SK-BR-3 breast cancer cells.
    Greenshields AL; Fernando W; Hoskin DW
    Exp Mol Pathol; 2019 Apr; 107():10-22. PubMed ID: 30660598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin reverses the sunitinib resistance in clear cell renal cell carcinoma (ccRCC) through the induction of ferroptosis via the
    Xu B; Zhu WJ; Peng YJ; Cheng SD
    Transl Cancer Res; 2021 Jul; 10(7):3158-3167. PubMed ID: 35116623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of artesunate for the treatment of adult T-cell leukemia/lymphoma.
    Ishikawa C; Senba M; Mori N
    Eur J Pharmacol; 2020 Apr; 872():172953. PubMed ID: 31996318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-130b Promotes Sunitinib Resistance through Regulation of PTEN in Renal Cell Carcinoma.
    Sekino Y; Sakamoto N; Sentani K; Oue N; Teishima J; Matsubara A; Yasui W
    Oncology; 2019; 97(3):164-172. PubMed ID: 31195398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-proliferative potential of Glucosamine in renal cancer cells via inducing cell cycle arrest at G0/G1 phase.
    Wang LS; Chen SJ; Zhang JF; Liu MN; Zheng JH; Yao XD
    BMC Urol; 2017 May; 17(1):38. PubMed ID: 28558682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular Adaptation to VEGF-Targeted Antiangiogenic Therapy Induces Evasive Resistance by Overproduction of Alternative Endothelial Cell Growth Factors in Renal Cell Carcinoma.
    Han KS; Raven PA; Frees S; Gust K; Fazli L; Ettinger S; Hong SJ; Kollmannsberger C; Gleave ME; So AI
    Neoplasia; 2015 Nov; 17(11):805-16. PubMed ID: 26678908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous targeting of Src kinase and receptor tyrosine kinase results in synergistic inhibition of renal cell carcinoma proliferation and migration.
    Bai L; Yang JC; Ok JH; Mack PC; Kung HJ; Evans CP
    Int J Cancer; 2012 Jun; 130(11):2693-702. PubMed ID: 21792888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of Artesunate on Proliferation, Cell Cycle and Apoptosis of SKM-1 Cells and Its Underlying Mechanisms].
    Qiao SK; Wang Y; Niu ZY; Tan JM; Wang JL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):131-7. PubMed ID: 26913409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NGAL can alternately mediate sunitinib resistance in renal cell carcinoma.
    Yu DS; Wu CL; Ping SY; Huang YL; Shen KH
    J Urol; 2014 Aug; 192(2):559-66. PubMed ID: 24423438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.